Discontinued — last reported Q4 '25
Johnson & Johnson Stock-Based Comp decreased by 15.4% to $347.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $295.00M to $347.00M.
An increase may signal a strategy to retain talent without using cash, but it also indicates future dilution for existing shareholders.
The value of equity-based awards granted to employees as part of their compensation package, recognized as an expense on...
High-growth software companies often have high SBC as a percentage of operating cash flow compared to mature industrial firms.
cf_stock_based_compensation| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $307.00M | $278.00M | $306.00M | $302.00M | $341.00M | $295.00M | $238.00M | $288.00M | $410.00M | $347.00M |
| QoQ Change | — | -9.4% | +10.1% | -1.3% | +12.9% | -13.5% | -19.3% | +21.0% | +42.4% | -15.4% |
| YoY Change | — | -9.4% | +10.1% | — | +11.4% | — | — | -4.6% | +20.2% | +17.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.